NXT-Dx is a private company specialized in next generation sequencing methylation analysis through MBD-based Genome-Wide Methylation Sequencing (Chip Seq) and Bisulphite sequencing. The company provides services for researchers worldwide involved/interested in epigenetics research.
Looking for a particular NXT-Dx employee's phone or email?
The NXT-Dx annual revenue was $1 million in 2026.
NXT-Dx is based in Gent, Flanders.
The NAICS codes for NXT-Dx are [5417, 541, 54, 541713, 54171].
The SIC codes for NXT-Dx are [87, 873].